GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzex Neuropharma Inc (OTCPK:TRRI) » Definitions » PB Ratio

Alzex Neuropharma (Alzex Neuropharma) PB Ratio : (As of Jun. 11, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Alzex Neuropharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-11), Alzex Neuropharma's share price is $0.1988. Alzex Neuropharma's Book Value per Share for the fiscal year that ended in . 20 was $0.00. Hence, Alzex Neuropharma's PB Ratio of today is .

The historical rank and industry rank for Alzex Neuropharma's PB Ratio or its related term are showing as below:

TRRI's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.46
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Alzex Neuropharma PB Ratio Historical Data

The historical data trend for Alzex Neuropharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzex Neuropharma PB Ratio Chart

Alzex Neuropharma Annual Data
Trend
PB Ratio

Alzex Neuropharma Quarterly Data
PB Ratio

Competitive Comparison of Alzex Neuropharma's PB Ratio

For the Biotechnology subindustry, Alzex Neuropharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzex Neuropharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzex Neuropharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alzex Neuropharma's PB Ratio falls into.



Alzex Neuropharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Alzex Neuropharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (A: . 20)
=0.1988/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Alzex Neuropharma  (OTCPK:TRRI) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Alzex Neuropharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Alzex Neuropharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzex Neuropharma (Alzex Neuropharma) Business Description

Traded in Other Exchanges
N/A
Address
8275 South Eastern Avenue, Suite 200-168, Las Vegas, NV, USA, 89123
Alzex Neuropharma Inc is a development-stage biopharmaceutical company that has developed and patented precision therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company currently holds two families of patents via an exclusive and unlimited licensing agreement with INSA (Institut National des Sciences Appliquees) a French academic engineering and research institute.

Alzex Neuropharma (Alzex Neuropharma) Headlines

No Headlines